How can the gene therapy industry drive down the cost of goods to better serve patients?

The cost per dose of viral vector therapeutics is a challenge for the widespread accessibility of gene therapy products. Manufacturers and solution providers can work together to ultimately make these drugs more cost-efficient to manufacture and ultimately reduce cost per dose. This article will discuss how tools such as process intensification (PI) and cost modeling can help build an understanding of the main cost drivers and the impact process optimization can have on the cost per dose.

Please enter your email to access content Read now